Thomas Decaens
Impact in
- Hepatology top 0.2%
- Hepatocellular Carcinoma Treatment and Prognosis
- Liver physiology and pathology
- Liver Disease and Transplantation
- Cancer Research top 5%
Papers in
- Hepatology 72
- Hepatocellular Carcinoma Treatment and Prognosis 62
- Liver physiology and pathology 16
- Hepatitis C virus research 11
- Epidemiology 32
- Liver Disease Diagnosis and Treatment 22
- Hepatitis B Virus Studies 12
- Co-authors
- Zuzana Macek Jílková (29 shared papers)Christine Perret (7 shared papers)Sabine Colnot (6 shared papers)Cécile Godard (4 shared papers)Christophe Duvoux (18 shared papers)Alexis Laurent (20 shared papers)Matthias S. Matter (2 shared papers)Snorri S. Thorgeirsson (2 shared papers)
- Journals
- Journal of Hepatology (17 papers)Annals of Oncology (13 papers)Journal of Clinical Oncology (10 papers)Cancers (8 papers)Liver International (6 papers)
- Partner nations
- FranceUnited StatesSouth Korea
In The Last Decade
Thomas Decaens
134 papers receiving 4.0k citations
Thomas Decaens's Hit Papers
Peers
Comparison fields: 5 of 96
- Hepatology 2.1k
- Cancer Research 454
- Epidemiology 989
- Oncology 551
- Pathology and Forensic Medicine 347
Countries citing papers authored by Thomas Decaens
This map shows the geographic impact of Thomas Decaens's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Thomas Decaens with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Thomas Decaens more than expected).
Fields of papers citing papers by Thomas Decaens
This network shows the impact of papers produced by Thomas Decaens. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Thomas Decaens. The network helps show where Thomas Decaens may publish in the future.
Co-authors
The 25 scholars most cited alongside Thomas Decaens, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 148 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2006 | 406 | |
| 2 | 2013 | 264 | |
| 3 | 2013 | 259 | |
| 4 | 2004 | 258 | |
| 5 | 2009 | 229 | |
| 6 | 2005 | 172 | |
| 7 | 2017 | 155 | |
| 8 | 2007 | 131 | |
| 9 | 2006 | 131 | |
| 10 | 2014 | 101 | |
| 11 | 2019 | 84 | |
| 12 | Nivolumab (NIVO) plus ipilimumab (IPI) vs lenvatinib (LEN) or sorafenib (SOR) as first-line treatment for unresectable hepatocellular carcinoma (uHCC): First results from CheckMate 9DW. Hit paper breakdown → | 2024 | 83 |
| 13 | 2018 | 67 | |
| 14 | 2013 | 61 | |
| 15 | 2018 | 58 | |
| 16 | 2017 | 54 | |
| 17 | 2012 | 54 | |
| 18 | 2019 | 53 | |
| 19 | 2006 | 50 | |
| 20 | 2021 | 50 |
About Thomas Decaens
Thomas Decaens is a scholar working on Hepatology, Epidemiology, Oncology, Molecular Biology and Surgery, having authored 148 papers that have together received 4.1k indexed citations. Recurring topics across this work include Hepatocellular Carcinoma Treatment and Prognosis (62 papers), Liver Disease Diagnosis and Treatment (22 papers), Liver physiology and pathology (16 papers), Cancer Immunotherapy and Biomarkers (15 papers), Hepatitis B Virus Studies (12 papers), Cancer Mechanisms and Therapy (12 papers), Hepatitis C virus research (11 papers) and PI3K/AKT/mTOR signaling in cancer (11 papers). The work is most often cited by research in Hepatology (2.1k citations), Cancer Research (454 citations), Epidemiology (989 citations), Oncology (551 citations) and Pathology and Forensic Medicine (347 citations). Thomas Decaens has collaborated with scholars based in France, United States and South Korea. Frequent co-authors include Zuzana Macek Jílková, Christine Perret, Sabine Colnot, Cécile Godard, Christophe Duvoux, Alexis Laurent, Matthias S. Matter, Snorri S. Thorgeirsson, Jesper B. Andersen and Gaël S. Roth. Their work appears in journals such as Journal of Hepatology, Annals of Oncology, Journal of Clinical Oncology, Cancers and Liver International.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.